These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3556260)

  • 41. Comparison of two bile acid-binding agents, cholestyramine and lignin.
    Heaton KW; Heaton ST; Barry RE
    Clin Sci; 1970 Apr; 38(4):25P. PubMed ID: 5428798
    [No Abstract]   [Full Text] [Related]  

  • 42. The affection of lipoprotein-a by lipid lowering drugs.
    Kostner GM
    Prog Clin Biol Res; 1988; 255():255-63. PubMed ID: 2963347
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug therapy in dyslipidemia.
    Grundy SM
    Scand J Clin Lab Invest Suppl; 1990; 199():63-72. PubMed ID: 2191420
    [No Abstract]   [Full Text] [Related]  

  • 44. Rational drug therapy of the hyperlipoproteinemias, Part II.
    Blum CB; Levy RI
    Ration Drug Ther; 1986 Oct; 20(10):1-4. PubMed ID: 3472266
    [No Abstract]   [Full Text] [Related]  

  • 45. [Drug interactions in the use of cardiac glycosides].
    Wirth KE
    Med Welt; 1981 Feb; 32(7):234-8. PubMed ID: 7010063
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.
    Neuvonen PJ; Kivistö K; Hirvisalo EL
    Br J Clin Pharmacol; 1988 Feb; 25(2):229-33. PubMed ID: 3358884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of cholesterol, cholic acid and cholestyramine administration on the intestinal mRNA expressions related to cholesterol and bile acid metabolism in the rat.
    Kamisako T; Ogawa H; Yamamoto K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1832-7. PubMed ID: 17498222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacologic therapy for the hyperlipidemic patient.
    Hunninghake DB
    Am J Med; 1983 May; 74(5A):19-22. PubMed ID: 6846378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of beta-cyclodextrin and resistant starch on bile acid metabolism and fecal steroid excretion in regard to their hypolipidemic action in hamsters.
    Trautwein EA; Forgbert K; Rieckhoff D; Erbersdobler HF
    Biochim Biophys Acta; 1999 Jan; 1437(1):1-12. PubMed ID: 9931405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of familial hypercholesterolemia with drugs in children.
    Stein EA
    Arteriosclerosis; 1989; 9(1 Suppl):I145-51. PubMed ID: 2912428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mechanism of action of drugs affecting lipid metabolism].
    Rossini L
    Minerva Med; 1975 Oct; 66(66):3458-68. PubMed ID: 1178137
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of cholestyramine on the absorption of vitamin D3 and calcium.
    Thompson WG; Thompson GR
    Gut; 1969 Sep; 10(9):717-22. PubMed ID: 4318526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro cholesterol synthesis in freshly isolated mononuclear cells of human blood: effect of in vivo administration of clofibrate and/or cholestyramine.
    McNamara DJ; Davidson NO; Fernandez S
    J Lipid Res; 1980 Jan; 21(1):65-71. PubMed ID: 7354255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antihyperlipidaemic agents. Drug interactions of clinical significance.
    Farmer JA; Gotto AM
    Drug Saf; 1994 Nov; 11(5):301-9. PubMed ID: 7873090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapy of hyperlipidemic states.
    Havel RJ; Kane JP
    Annu Rev Med; 1982; 33():417-33. PubMed ID: 7044276
    [No Abstract]   [Full Text] [Related]  

  • 56. In vivo meal model for the evaluation of agents which affect the absorption of triglyceride and cholesterol.
    Comai K; Sullivan AC
    Biochem Pharmacol; 1980 Jun; 29(11):1475-82. PubMed ID: 7396983
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of polybasic antibiotics and sulfaguanidine on absorption and excretion of cholesterol and bile salts.
    Eyssen H; Vanderhaeghe H; De Somer P
    Fed Proc; 1971; 30(6):1803-7. PubMed ID: 5124964
    [No Abstract]   [Full Text] [Related]  

  • 58. Polymeric sorbents for bile acids. I: Comparison between cholestyramine and colestipol.
    Zhu XX; Brown GR; St-Pierre LE
    J Pharm Sci; 1992 Jan; 81(1):65-9. PubMed ID: 1619572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of cholestyramine and colestipol on the absorption of diclofenac in man.
    al-Balla SR; el-Sayed YM; al-Meshal MA; Gouda MW
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):441-5. PubMed ID: 7981930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional activities of hepatic lipoprotein receptors.
    Havel RJ
    Annu Rev Physiol; 1986; 48():119-34. PubMed ID: 3010812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.